: The original version of the drug was derived from human placental tissue, making it extremely difficult and expensive to produce at the time.
(also known as Ceredase) is a landmark in pharmaceutical history as the first enzyme replacement therapy (ERT) approved by the FDA in 1991.
: The success of Seriday transformed Genzyme into a biotech giant (later acquired by Sanofi for $20 billion) and paved the way for modern recombinant DNA versions like Cerezyme.
: The original version of the drug was derived from human placental tissue, making it extremely difficult and expensive to produce at the time.
(also known as Ceredase) is a landmark in pharmaceutical history as the first enzyme replacement therapy (ERT) approved by the FDA in 1991.
: The success of Seriday transformed Genzyme into a biotech giant (later acquired by Sanofi for $20 billion) and paved the way for modern recombinant DNA versions like Cerezyme.
